plerixafor has been researched along with Centriacinar Emphysema in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albrecht, ME; Barwinska, D; Bogatcheva, NV; Broxmeyer, HE; Justice, MJ; March, KL; Oueini, H; Petrache, I; Poirier, C; Saliba, J; Schweitzer, KS | 1 |
1 other study(ies) available for plerixafor and Centriacinar Emphysema
Article | Year |
---|---|
AMD3100 ameliorates cigarette smoke-induced emphysema-like manifestations in mice.
Topics: Animals; Benzylamines; Bone Marrow; Chemokine CXCL12; Cyclams; Female; Hematopoietic Stem Cells; Heterocyclic Compounds; Lung Injury; Mice; Pulmonary Alveoli; Pulmonary Emphysema; Receptors, CXCR4; Smoking | 2018 |